• Explore /
  • Poster
  • / Tumor mutational burden as a potential predictive marker for the efficacy of immunotherapy in advanced gastric cancer.

Tumor mutational burden as a potential predictive marker for the efficacy of immunotherapy in advanced gastric cancer.

Abstract Poster

Authors

null

Jae Yeon Jang

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;

Jae Yeon Jang , Sun Young Jeong , Seung Tae Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 324)

DOI

10.1200/JCO.2023.41.4_suppl.324

Abstract #

324

Poster Bd #

D5

Abstract Disclosures

Similar Posters

First Author: Jwa Hoon Kim

Poster

2021 Gastrointestinal Cancers Symposium

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.

First Author: Marwan Fakih

First Author: Panpan Zhang

First Author: Mark Chang